Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001127602-25-012380
Filing Date
2025-04-21
Accepted
2025-04-21 16:09:13
Documents
2
Period of Report
2025-04-17

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form3.html 3  
1 PRIMARY DOCUMENT form3.xml 3 1393
2 POWER OF ATTORNEY (PUBLIC): POA doc1.txt EX-24 3921
  Complete submission text file 0001127602-25-012380.txt   6589
Mailing Address
Business Address
WHEELER CRAIG A (Reporting) CIK: 0001229450 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38276 | Film No.: 25853221

Mailing Address 100 FIFTH AVENUE WALTHAM MA 02451
Business Address 100 FIFTH AVENUE WALTHAM MA 02451 617-977-5700
Apellis Pharmaceuticals, Inc. (Issuer) CIK: 0001492422 (see all company filings)

EIN.: 271537290 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)